Trang chủ › Ung thư hắc tố › Texas › Houston
Thử nghiệm lâm sàng cho Ung thư hắc tố tại Houston, TX
61 nghiên cứu cho Ung thư hắc tố đang tìm kiếm người tham gia tại các cơ sở ở Houston và vùng lân cận (bán kính khoảng 30 dặm). Mở nghiên cứu để xem tiêu chí tham gia và cách liên hệ với đội ngũ nghiên cứu.
Văn bản nghiên cứu chính thức (Tiếng Anh)
Đang tuyển dụng cho một nghiên cứu? Đưa tin của bạn lên đầu trang này — $99 trong 30 ngày →
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
Đang tuyển
- M D Anderson Cancer Center, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Đang tuyểnNghiên cứu quan sát
- M D Anderson Cancer Center, Houston
BostonGene and Exigent Genomic INsight Study
Đang tuyểnNghiên cứu quan sát
- Oncology Consultants, Houston
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Đang tuyểnGiai đoạn 1
- University of Texas MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
Đang tuyển
- M D Anderson Cancer Center, Houston
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Đang tuyểnGiai đoạn 1
- The University of Texas MD Anderson Cancer Center, Houston
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Đang tuyểnGiai đoạn 3
- The University of Texas MD Anderson Cancer Center, Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- UT MD Anderson Cancer Center, Houston
SI-B036-ST-101 in Advanced/Metastatic Solid Tumors
Đang tuyểnGiai đoạn 1
- MD Anderson, Houston
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Đang tuyểnGiai đoạn 2
- University of Texas MD Anderson Cancer Center, Houston
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- M.D. Anderson Cancer Center (Melanoma/NSCLC), Houston
Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases
Đang tuyểnGiai đoạn 1
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of BI 3810944 in Patients With Advanced Cancer
Đang tuyểnGiai đoạn 1
- The University of Texas MD Anderson Cancer Center, Houston
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Đang tuyểnGiai đoạn 2
- USA12-0, Houston
A Study of MGC026 in Participants With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Đang tuyểnGiai đoạn 2
- The University of Texas MD Anderson Cancer Center, Houston
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- University of Texas-MD Anderson, Houston
- Lumi Research, Houston
Intratumoral N17350 in Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Đang tuyểnGiai đoạn 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Đang tuyểnGiai đoạn 1/2
- Research Site, Houston
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Đang tuyểnNghiên cứu quan sát
- M D Anderson Cancer Center, Houston
Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- M D Anderson Cancer Center, Houston
Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
Đang tuyểnGiai đoạn 2
- MD Anderson Cancer Center, Houston
Pan-tumor MRD Study
Đang tuyểnNghiên cứu quan sát
- Onocology Consultants P.A. (Oncology Consultants [OC Houston]), Houston
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Đang tuyểnGiai đoạn 2
- UT MD Anderson Cancer Center, Houston
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Đang tuyểnGiai đoạn 1/2
- MD Anderson Cancer Center, Houston
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Đang tuyểnGiai đoạn 1
- M D Anderson Cancer Center, Houston
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Đang tuyểnGiai đoạn 1
- MD Anderson, Houston
Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)
Đang tuyểnGiai đoạn 1/2
- The University of Texas M. D. Anderson Cancer Center, Houston
Project: Every Child for Younger Patients With Cancer
Đang tuyểnNghiên cứu quan sát
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Đang tuyểnGiai đoạn 1/2
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Đang tuyểnNghiên cứu quan sát
- M D Anderson Cancer Center, Houston
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- Houston Methodist Hospital, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
Đang tuyểnGiai đoạn 2
- M D Anderson Cancer Center, Houston
IDOV-Immune for Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
Đang tuyểnGiai đoạn 2
- M D Anderson Cancer Center, Houston
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
Đang tuyểnGiai đoạn 2
- M D Anderson Cancer Center, Houston
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Đang tuyểnGiai đoạn 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Đang tuyểnGiai đoạn 1/2
- The University of Texas MD Anderson Cancer Center, Houston
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Đang tuyểnGiai đoạn 1/2
- University of Texas MD Anderson Cancer Center, Houston
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Đang tuyểnGiai đoạn 3
- Retina Consultants of Texas - (Houston), Houston
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
Đang tuyểnNghiên cứu quan sát
- M D Anderson Cancer Center, Houston
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Đang tuyểnGiai đoạn 1/2
- MD Anderson Cancer Center, Houston
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
Đang tuyểnGiai đoạn 2
- M D Anderson Cancer Center, Houston
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Đang tuyển
- M D Anderson Cancer Center, Houston
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Đang tuyểnGiai đoạn 1/2
- MD Anderson Cancer Center, Houston
A Study of VET3-TGI in Patients With Solid Tumors
Đang tuyểnGiai đoạn 1
- University of Texas MD Anderson Cancer Center, Houston
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Đang tuyểnGiai đoạn 2/3
- The University Of Texas Md Anderson Cancer Center, Houston
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Đang tuyểnGiai đoạn 3
- Houston Methodist Hospital/Houston Methodist Cancer Center, Houston
ACTengine® IMA203 Combined With mRNA-4203
Đang tuyểnGiai đoạn 1
- MD Anderson Cancer Center, Houston
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Đang tuyểnGiai đoạn 3
- The University of Texas M.D. Anderson Cancer Center, Houston
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Đang tuyểnGiai đoạn 1/2
- The University of Texas MD Anderson Cancer Center, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Đang tuyểnNghiên cứu quan sát
- Massive Bio SYNERGY-AI site, Houston
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Đang tuyểnGiai đoạn 1/2
- MD Anderson Cancer Center, Houston
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Đang tuyểnGiai đoạn 1/2
- Oncology Consultants, P.A., Houston
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Đang tuyểnGiai đoạn 2
- MD Anderson Cancer Center-University of Texas, Houston
- Oncology Consultants P.A., Houston
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Đang tuyển
- The University of Texas MD Anderson Cancer Center, Houston
Thử nghiệm cho Ung thư hắc tố tại các thành phố khác
- New York City, NY41 nghiên cứu
- Nashville, TN34 nghiên cứu
- Los Angeles, CA34 nghiên cứu
- Pittsburgh, PA31 nghiên cứu
- Boston, MA25 nghiên cứu
- St. Louis, MO23 nghiên cứu
- Durham, NC22 nghiên cứu
- Philadelphia, PA22 nghiên cứu
- Tampa, FL21 nghiên cứu
- Columbus, OH21 nghiên cứu
- Dallas, TX21 nghiên cứu
- San Francisco, CA21 nghiên cứu
Các nghiên cứu khác tại Houston
- Ung thư phổi không tế bào nhỏ143 nghiên cứu
- Ung thư vú126 nghiên cứu
- Ung thư (mọi loại)124 nghiên cứu
- Ung thư đại trực tràng101 nghiên cứu
- Ung thư di căn100 nghiên cứu
- Ung thư buồng trứng90 nghiên cứu
- Bạch cầu tủy cấp88 nghiên cứu
- Ung thư phổi78 nghiên cứu
- Ung thư tuyến tiền liệt73 nghiên cứu
- Ung thư nội mạc tử cung69 nghiên cứu
- Ung thư tụy59 nghiên cứu
- Ung thư biểu mô tế bào vảy ở đầu và cổ49 nghiên cứu
Nguồn dữ liệu từ ClinicalTrials.gov, cập nhật ngày 15 thg 11, 2026. Mỗi nghiên cứu có tiêu chí riêng; đội ngũ nghiên cứu sẽ quyết định ai đủ điều kiện tham gia.